250 related articles for article (PubMed ID: 7845021)
21. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205
[TBL] [Abstract][Full Text] [Related]
22. Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved.
Ouspenskaia MV; Johnston DA; Roberts WM; Estrov Z; Zipf TF
Leukemia; 1995 Feb; 9(2):321-8. PubMed ID: 7869771
[TBL] [Abstract][Full Text] [Related]
23. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of heavy chain immunoglobulins gene and T-cell receptor delta gene in children with acute leukemia].
Pan Q; Chou Y; Hong W
Zhonghua Yi Xue Za Zhi; 1995 Sep; 75(9):529-31, 573. PubMed ID: 8556542
[TBL] [Abstract][Full Text] [Related]
25. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
[TBL] [Abstract][Full Text] [Related]
26. Consensus JH gene probes with conjugated 3'-minor groove binder for monitoring minimal residual disease in acute lymphoblastic leukemia.
Uchiyama M; Maesawa C; Yashima-Abo A; Tarusawa M; Endo M; Sugawara W; Chida S; Onodera S; Tsukushi Y; Ishida Y; Tsuchiya S; Masuda T
J Mol Diagn; 2005 Feb; 7(1):121-6. PubMed ID: 15681483
[TBL] [Abstract][Full Text] [Related]
27. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia.
Verhagen OJ; Willemse MJ; Breunis WB; Wijkhuijs AJ; Jacobs DC; Joosten SA; van Wering ER; van Dongen JJ; van der Schoot CE
Leukemia; 2000 Aug; 14(8):1426-35. PubMed ID: 10942239
[TBL] [Abstract][Full Text] [Related]
28. [Junctional sequences of T cell receptor V delta 2-D delta 3 or D delta 2-D delta 3 rearrangements in acute lymphoblastic leukemia].
Kuang S; Dong S; Gu L
Zhonghua Yi Xue Za Zhi; 1995 Sep; 75(9):532-6, 574. PubMed ID: 8556543
[TBL] [Abstract][Full Text] [Related]
29. Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients.
Toubai T; Tanaka J; Ota S; Fukuhara T; Hashino S; Kondo T; Kasai M; Kakinoki Y; Masauzi N; Morioka M; Kawamura T; Iwasaki H; Asaka M; Imamura M
Am J Hematol; 2005 Nov; 80(3):181-7. PubMed ID: 16247752
[TBL] [Abstract][Full Text] [Related]
30. Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping.
Malec M; van der Velden VH; Björklund E; Wijkhuijs JM; Söderhäll S; Mazur J; Björkholm M; Porwit-MacDonald A
Leukemia; 2004 Oct; 18(10):1630-6. PubMed ID: 15295608
[TBL] [Abstract][Full Text] [Related]
31. Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin.
Beishuizen A; Hählen K; Hagemeijer A; Verhoeven MA; Hooijkaas H; Adriaansen HJ; Wolvers-Tettero IL; van Wering ER; van Dongen JJ
Leukemia; 1991 Aug; 5(8):657-67. PubMed ID: 1909409
[TBL] [Abstract][Full Text] [Related]
32. Gamma and delta chain gene rearrangement of T cell receptor in acute lymphoblastic leukemia.
Tong JH; Dong S; Chen Y; Qian ZZ; Gu LJ; Zhang YM; Wang ZY; Chen SJ; Chen Z
Chin Med J (Engl); 1994 Jan; 107(1):12-8. PubMed ID: 8187567
[TBL] [Abstract][Full Text] [Related]
33. Residual disease detection in multiple follow-up samples in children with acute lymphoblastic leukemia.
Kitchingman GR
Leukemia; 1994 Mar; 8(3):395-401. PubMed ID: 8127144
[TBL] [Abstract][Full Text] [Related]
34. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.
Nakao M; Janssen JW; Flohr T; Bartram CR
Cancer Res; 2000 Jun; 60(12):3281-9. PubMed ID: 10866322
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of the T-cell receptor delta gene indicating subclone formation in acute precursor B-cell leukemias.
Ghali DW; Panzer S; Fischer S; Argyriou-Tirita A; Haas OA; Kovar H; Gadner H; Panzer-Grümayer ER
Blood; 1995 May; 85(10):2795-801. PubMed ID: 7742540
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL.
Garand R; Beldjord K; Cavé H; Fossat C; Arnoux I; Asnafi V; Bertrand Y; Boulland ML; Brouzes C; Clappier E; Delabesse E; Fest T; Garnache-Ottou F; Huguet F; Jacob MC; Kuhlein E; Marty-Grès S; Plesa A; Robillard N; Roussel M; Tkaczuk J; Dombret H; Macintyre E; Ifrah N; Béné MC; Baruchel A
Leukemia; 2013 Feb; 27(2):370-6. PubMed ID: 23070018
[TBL] [Abstract][Full Text] [Related]
37. Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia.
Brüggemann M; van der Velden VH; Raff T; Droese J; Ritgen M; Pott C; Wijkhuijs AJ; Gökbuget N; Hoelzer D; van Wering ER; van Dongen JJ; Kneba M
Leukemia; 2004 Apr; 18(4):709-19. PubMed ID: 14961040
[TBL] [Abstract][Full Text] [Related]
38. Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia.
Donovan JW; Ladetto M; Zou G; Neuberg D; Poor C; Bowers D; Gribben JG
Blood; 2000 Apr; 95(8):2651-8. PubMed ID: 10753847
[TBL] [Abstract][Full Text] [Related]
39. [Children with acute lymphoblastic leukemia: prognostic significance of polymerase-chain-reaction analysis of minimal residual disease].
Steenbergen EJ; Verhagen OJ; van den Berg H; van Leeuwen EF; von dem Borne AE; van der Schoot CE
Ned Tijdschr Geneeskd; 1996 Jan; 140(1):22-8. PubMed ID: 8569906
[TBL] [Abstract][Full Text] [Related]
40. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.
van der Velden VH; Jacobs DC; Wijkhuijs AJ; Comans-Bitter WM; Willemse MJ; Hählen K; Kamps WA; van Wering ER; van Dongen JJ
Leukemia; 2002 Aug; 16(8):1432-6. PubMed ID: 12145681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
